AI-Driven Biomarker Predicts Prostate Cancer Outcomes
The tool, based on histology only, may help identify patients most likely to benefit from triplet therapy. Medscape Medical News
Read the full articleYou might also wanna read
UC San Diego AI Model Predicts Cancer Treatment Response from Tumor Genetics
A new AI model developed by UC San Diego researchers could make it possible to predict treatment response based only on a tumor's genetics.
AI tool analyzes tumour images to guide treatment for common brain cancer
Researchers have developed an Artificial Intelligence (AI) tool that could one day help tailor treatment for meningioma.
CHAI-Powered Biomarker in mHSPC From CHAARTED and ENZAMET Phase 3 Trials
Metastatic hormone-sensitive prostate cancer is no longer approached as a single clinical entity. With androgen-deprivation therapy, androge
Teaching Machines to See Medicine: How AI is Learning to Think Like a Doctor Across Every Medical Specialty
When you visit a doctor, they don't just look at one thing. Your physician might listen to your heart, examine an X-ray, review your blood w
Development and Validation of a Non-Invasive AI Diagnostic Model for Prostate Cancer Using Multiparametric MRI and PSMA PET/CT
Conditions : Prostate Cancer (Diagnosis) Sponsors : Xiangya Hospital of Central South University; Qilu Hospital of Shandong University; Chin

Comments
Sign in to join the conversation.
No comments yet. Be the first.